These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16315222)

  • 1. Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate.
    Remmele RL; Callahan WJ; Krishnan S; Zhou L; Bondarenko PV; Nichols AC; Kleemann GR; Pipes GD; Park S; Fodor S; Kras E; Brems DN
    J Pharm Sci; 2006 Jan; 95(1):126-45. PubMed ID: 16315222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermolecular interactions and conformation of antibody dimers present in IgG1 biopharmaceuticals.
    Iwura T; Fukuda J; Yamazaki K; Kanamaru S; Arisaka F
    J Biochem; 2014 Jan; 155(1):63-71. PubMed ID: 24155259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs.
    Plath F; Ringler P; Graff-Meyer A; Stahlberg H; Lauer ME; Rufer AC; Graewert MA; Svergun D; Gellermann G; Finkler C; Stracke JO; Koulov A; Schnaible V
    MAbs; 2016 Jul; 8(5):928-40. PubMed ID: 27031922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy.
    Lee YC; Boehm MK; Chester KA; Begent RH; Perkins SJ
    J Mol Biol; 2002 Jun; 320(1):107-27. PubMed ID: 12079338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular perspective of antibody aggregates and their adsorption on Protein A resin.
    Yu D; Song Y; Huang RY; Swanson RK; Tan Z; Schutsky E; Lewandowski A; Chen G; Li ZJ
    J Chromatogr A; 2016 Jul; 1457():66-75. PubMed ID: 27344283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain.
    McAuley A; Jacob J; Kolvenbach CG; Westland K; Lee HJ; Brych SR; Rehder D; Kleemann GR; Brems DN; Matsumura M
    Protein Sci; 2008 Jan; 17(1):95-106. PubMed ID: 18156469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of Fab fragments from a monoclonal antibody papain digest by Gradiflow electrophoresis.
    Coleman L; Mahler SM
    Protein Expr Purif; 2003 Dec; 32(2):246-51. PubMed ID: 14965770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidation of two major aggregation pathways in an IgG2 antibody.
    Van Buren N; Rehder D; Gadgil H; Matsumura M; Jacob J
    J Pharm Sci; 2009 Sep; 98(9):3013-30. PubMed ID: 18680168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
    Wolff EA; Schreiber GJ; Cosand WL; Raff HV
    Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells.
    Merz GS; Benedikz E; Schwenk V; Johansen TE; Vogel LK; Rushbrook JI; Wisniewski HM
    J Cell Physiol; 1997 Dec; 173(3):423-32. PubMed ID: 9369956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of group A streptococcus Mac-1: insight into dimer-mediated specificity for recognition of human IgG.
    Agniswamy J; Nagiec MJ; Liu M; Schuck P; Musser JM; Sun PD
    Structure; 2006 Feb; 14(2):225-35. PubMed ID: 16472742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two routes for production and purification of Fab fragments in biopharmaceutical discovery research: Papain digestion of mAb and transient expression in mammalian cells.
    Zhao Y; Gutshall L; Jiang H; Baker A; Beil E; Obmolova G; Carton J; Taudte S; Amegadzie B
    Protein Expr Purif; 2009 Oct; 67(2):182-9. PubMed ID: 19442740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monomer-dimer equilibrium constants of RNA in the dimer initiation site of human immunodeficiency virus type 1.
    Shubsda MF; McPike MP; Goodisman J; Dabrowiak JC
    Biochemistry; 1999 Aug; 38(31):10147-57. PubMed ID: 10433723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring papain digestion of a monoclonal antibody by electrospray ionization mass spectrometry.
    Bennett KL; Smith SV; Truscott RJ; Sheil MM
    Anal Biochem; 1997 Feb; 245(1):17-27. PubMed ID: 9025964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of monoclonal antibody alemtuzumab monomer and dimers using ultrafiltration.
    Wan Y; Vasan S; Ghosh R; Hale G; Cui Z
    Biotechnol Bioeng; 2005 May; 90(4):422-32. PubMed ID: 15812802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of degradation processes in IgG1 monoclonal antibodies by limited proteolysis coupled with weak cation-exchange HPLC.
    Lau H; Pace D; Yan B; McGrath T; Smallwood S; Patel K; Park J; Park SS; Latypov RF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):868-76. PubMed ID: 20206584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protein cryoconcentration and processing conditions on kinetics of dimer formation for a monoclonal antibody: A case study on bioprocessing.
    Mehta SB; Subramanian S; D'Mello R; Brisbane C; Roy S
    Biotechnol Prog; 2019 Jul; 35(4):e2836. PubMed ID: 31063635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.
    Cheetham GM; Hale G; Waldmann H; Bloomer AC
    J Mol Biol; 1998 Nov; 284(1):85-99. PubMed ID: 9811544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.